Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2014
04/03/2014US20140094518 Method for regulating retinal endothelial cell viability
04/03/2014US20140094516 Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
04/03/2014US20140094513 Composition and method for neuroprotection against excitotoxic injury
04/03/2014US20140094511 Treatment of Obstructive Sleep Apnea Syndrome with a Combination of a Carbonic Anhydrase Inhibitor and an Additional Active Agent
04/03/2014US20140094510 Non-aqueous taxane nanodispersion formulations and methods of using the same
04/03/2014US20140094509 Non-aqueous taxane nanodispersion formulations and methods of using the same
04/03/2014US20140094502 RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS
04/03/2014US20140094499 Formulations of (r)-1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide
04/03/2014US20140094498 Methods and compositions for treating post-operative pain comprising clonidine
04/03/2014US20140094497 Angiotensin in Treating Brain Conditions
04/03/2014US20140094496 Formulations of bendamustine
04/03/2014US20140094494 Antifungal Treatment
04/03/2014US20140094488 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
04/03/2014US20140094486 Solid state forms of hiv inhibitor
04/03/2014US20140094485 Solid state forms of hiv inhibitor
04/03/2014US20140094484 Sustained delivery formulations of rapamycin compounds
04/03/2014US20140094482 Benzazocine-ring compound inhibition of tau hyperphosphorylation
04/03/2014US20140094481 Tamper resistant dosage forms
04/03/2014US20140094478 Composition and tablet comprising raltegravir
04/03/2014US20140094470 Combination treatment for dermatological conditions
04/03/2014US20140094469 Methods and compositions for safe and effective treatment of erythema
04/03/2014US20140094467 Method and composition for modulating canonical wnt pathway using folate and inositol
04/03/2014US20140094461 Biomarkers for hedgehog inhibitor therapy
04/03/2014US20140094459 Tyrosine Kinase Inhibitors
04/03/2014US20140094458 Cyclic Progestin Regimens and Kits
04/03/2014US20140094457 Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated rna decay
04/03/2014US20140094452 Rapid Onset Liquid Midazolam Composition for Buccal Administration
04/03/2014US20140094451 Preventive or remedy for glaucoma
04/03/2014US20140094449 Treatment of bipolar disorder
04/03/2014US20140094448 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
04/03/2014US20140094447 Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
04/03/2014US20140094446 Cyclic Amino Acids for the Treatment of Pain
04/03/2014US20140094444 Compositions and methods for tissue engineering and cell based therapies
04/03/2014US20140094442 Combinations comprising anti-muscarinic agents and corticosteroids
04/03/2014US20140094441 Natural combination hormone replacement formulations and therapies
04/03/2014US20140094440 Natural combination hormone replacement formulations and therapies
04/03/2014US20140094439 pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
04/03/2014US20140094438 Compositions and methods for the treatment of pain
04/03/2014US20140094437 High alcohol content foaming compositions
04/03/2014US20140094435 Use of Dextran Sulfate
04/03/2014US20140094434 Amino acid composition
04/03/2014US20140094430 Hyaluronic acid compositions stabilised against the degrading effect of heat or enzymes
04/03/2014US20140094428 Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia
04/03/2014US20140094427 Dosing methods for treating disease
04/03/2014US20140094425 Methods for transdifferentiation of body tissues
04/03/2014US20140094421 Herbal medicinal composition for treatment of women infertility and a method of preparing the same
04/03/2014US20140094418 Palatable ductile chewable veterinary composition
04/03/2014US20140094408 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome
04/03/2014US20140093598 Compounds and extracts from gnetum africanum and anti-inflammatory activity related thereto
04/03/2014US20140093594 Composition to Enhance the Bioavailability of Curcumin
04/03/2014US20140093592 Esketamine for the treatment of treatment-refractory or treatment-resistant depression
04/03/2014US20140093587 Peelable film-forming compositions and methods of using the same
04/03/2014US20140093586 Oral rehydration composition
04/03/2014US20140093585 Parp inhibitors for the treatment of cipn
04/03/2014US20140093583 Povidone-iodine topical composition
04/03/2014US20140093582 Formulation for treatment of dry mouth and mouth sores
04/03/2014US20140093578 Novel clonidine formulation
04/03/2014US20140093576 Pharmaceutical Dosage Form with Multiple Coatings for Reduced Impact of Coating Fractures
04/03/2014US20140093573 Non-enteric coated pharmaceutical composition and use thereof
04/03/2014US20140093569 Morphine polymer release system
04/03/2014US20140093568 Combination therapies
04/03/2014US20140093566 Pharmaceutical formulations of a substituted diaminopurine
04/03/2014US20140093565 A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof
04/03/2014US20140093564 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with simvastatin
04/03/2014US20140093563 Febuxostat compositions
04/03/2014US20140093562 Solid naproxen concentrates and related dosage forms
04/03/2014US20140093561 Oral dosage forms of cyclopropanecarboxylic acid -amide
04/03/2014US20140093560 Methods and materials for the treatment of testosterone deficiency in men
04/03/2014US20140093559 Abuse-proofed dosage form
04/03/2014US20140093558 Stable crystal modifications of dotap chloride
04/03/2014US20140093557 Exosomal compositions and methods for the treatment of disease
04/03/2014US20140093555 Patch preparation containing amine oxide
04/03/2014US20140093554 Nutritional compositions with large lipid globule size
04/03/2014US20140093546 Implants for administering substances and methods of producing implants
04/03/2014US20140093513 Methods of lowering proprotein conversate subtilisin/kexin type 9 (pcsk9)
04/03/2014US20140093505 Pyridonaphthyridine PI3K/MTOR Dual Inhibitors and Preparation and Use Thereof
04/03/2014US20140093503 Taxane and Abeo-Taxane Analogs
04/03/2014US20140093502 Immunosuppressive Combination and Its Use in the Treatment or Prophylaxis of Insulin-producing Cell Graft Rejection
04/03/2014US20140093499 Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf agents
04/03/2014US20140093498 Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf-r agents
04/03/2014US20140093494 Alpha synuclein toxicity
04/03/2014US20140093490 Glutamate release from astrocyte
04/03/2014US20140093489 Nutritional supplements for eye health and related methods
04/03/2014US20140093484 Use of Dextran Sulfate
04/03/2014US20140093472 L-histidine in ophthalmic solutions
04/03/2014US20140093466 Hair care compositions and methods of use
04/03/2014US20140093449 Method for Preparing Largazole Analogs and Uses Thereof
04/03/2014DE102012019369A1 7-Azaindolderivat 7-Azaindolderivat
04/02/2014EP2712928A1 Method for producing natural -carotene by fermentation and use thereof
04/02/2014EP2712926A2 Compositions and methods for inhibiting expression of Eg5 and VEGF genes
04/02/2014EP2712868A1 5-Fluoruoracil Derivatives
04/02/2014EP2712867A1 Compositions of tetrazole derivatives of sirolimus and anti-oxidants
04/02/2014EP2712866A1 1,2,4-triazine derivatives for the treatment of viral infections
04/02/2014EP2712865A1 Improved process for the preparation of ambrisentan
04/02/2014EP2712863A1 Novel inhibitors of bacterial biofilms and related methods
04/02/2014EP2712862A1 New anti-invasive compounds
04/02/2014EP2712861A1 Thioacetate compounds, compositions and methods of use
04/02/2014EP2712655A1 Inhibitors of histone deacetylase
04/02/2014EP2712621A1 Pharmaceutical composition for treating hyperproliferative diseases
04/02/2014EP2712618A1 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
1 ... 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 ... 7860